Related Experiment Video
Updated: May 24, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
31.8K
Severe asthma beyond bronchodilators: Emerging therapeutic approaches
Muhammad Qasim Barkat1, Majid Manzoor1, Chengyun Xu2
1Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China.
International Immunopharmacology
|March 6, 2025
Summary
New asthma therapies target inflammation and airway remodeling. Innovative treatments like CRTH2 antagonists and PDE inhibitors offer hope for severe asthma management beyond current standards.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Asthma involves reversible airway inflammation, obstruction, and remodeling.
- Inflammatory cells (eosinophils, lymphocytes, mast cells) and cytokines contribute to asthma development.
- Current treatments (bronchodilators, anti-inflammatories) are effective but insufficient for severe cases.
Purpose of the Study:
- To review innovative therapies for severe asthma.
- To explore novel agents that may alter asthma's disease course.
- To highlight treatments targeting specific inflammatory pathways.
Main Methods:
- Literature review of recent research on asthma therapies.
- Focus on novel pharmacological interventions and biological agents.
- Analysis of mechanisms of action for new therapeutic targets.
Main Results:
- Chemoattractant receptor-homologous molecule expressed on Th2 cell (CRTH2) antagonists show promise.
- S-nitrosoglutathione reductase (GSNOR) and phosphodiesterase (PDE) inhibitors offer new treatment avenues.
- Novel biological agents present potential for improved severe asthma control.
Conclusions:
- Innovative therapies offer new strategies for managing severe asthma.
- Targeting specific inflammatory pathways may alter disease progression.
- Further research into these novel agents is warranted for clinical application.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
211
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
211
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
214
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
214
01:17Drugs Used in Lower Respiratory Disorders: Overview
333
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
333
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
314
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
314
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170